NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » TOP 50 Pharmas » Roche  1    
found files: 11
Roche »30/10/2007 [Company watch]
Roche Drug center in Shanghai to tackle cancer and diabetes

Shanghai's first international drug development center was launched Monday to help Chinese researchers and patients become involved in international trials for new medicines. The Pharma Development Center in China, which is backed by the international pharmaceutical company Roche, is a high tech drug development center designed to effectively carry out all the stages of drug development from discovery to clinical development, trials and official paper work....   more»

Roche »17/05/2008
Shanghai Roche Pharmaceutical to donate lung cancer drug to Chinese patients

Shanghai Roche Pharmaceutical announced in a May 15 press conference that it will donate supplies of Tarceva worth RMB 98 million to Chinese lung cancer patients unable to afford the drug. The drug will be given to patients in 21 cities across the country in October this year. According to clinical trial statistics by TRUST, Tarceva has a disease control rate of 79% in treating China patients with advanced non-small cell lung cancer. TRUST, the largest and longest ongoing study of Tarceva in lung cancer worldwide, involves nearly 12,000 NSCLC patients from 59 countries across Asia, the Middle East, Europe and the Americas...   more»

Roche »29/08/2008 [Company watch]
Roche oral chemotherapeutic Xeloda granted SFDA approval

Shanghai Roche Pharmaceuticals, the China branch of multinational giant Roche, announced on August 26th that it has obtained approval from the SFDA to market its oral chemotherapy drug Xeloda (capecitabine) in China as a first line treatment for late stage gastric cancer. The drug provides an alternative to standard intravenous injection chemotherapies. The product, a 5-FU prodrug, is approved in the United States for treatment of both metastatic colorectal and breast cancers...   more»

Roche »07/11/2008 [Company watch]
Roche Intent on Discovering Innovative Medicines in China

Roche has broken ground on an expansion of its facilities at its site in Shanghai’s Zhangjiang Hi-Tech Park, an ambitious expansion that seeks to provide the backbone for the next ten years of the company’s China growth....   more»

Roche »17/11/2008 [Company watch]
European drug giant Roche is expanding its Shanghai facility in China

European drug giant Roche is expanding its Shanghai facility in China to bolster business in the world’s fastest growing economy and to develop innovative drugs in China....   more»

Roche »07/02/2009 [Industry news]
Roche Seeks Biotech Licensing, Takeovers in China

Roche Holding AG, Switzerland’s biggest drugmaker, may make its first acquisition of a Chinese biotechnology company or buy rights to a compound developed in the country later this year....   more»

Roche »27/05/2009 [Company watch]
Roche Applied Science Opens Application Support Centre in Shanghai

.... Staffed with experts skilled in applying a broad range of technologies to a diverse range of life science research topics......   more»

Roche »05/11/2009 [Industry news]
Roche Opens Singapore Manufacturing Facility for Projects Initiated by Genentech

Roche has opened a new $500 million biologics manufacturing facility in Singapore in the Tuas Biomedical Park....   more»

Roche »17/12/2009 [Industry news]
Roche lends helping hand to MOH to support organ transplant programs

Roche Pharmaceuticals is teaming up with the Ministry of Health (MOH) to launch the China Organ Transplant Development Program, according to Beijing Youth Daily December 16....   more»

Roche »11/02/2010 [Industry news]
CapitalBio Corporation Certified to Provide Roche NimbleGen, Inc Array Services in China

Roche NimbleGen announced today that Beijing-based genomic services provider CapitalBio has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program....   more»

Roche »16/05/2010 [Company watch]
Roche Diagnostics Growing at 50% Rate in China

Roche Diagnostics has been experiencing annual revenue increases of close to 50% per year, and the company expects the large increases to continue, driven by the PRC’s investment into healthcare. Roche Diagnostics thinks China will soon become its fifth largest market, up from eighth last year....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.